Fisher & Paykel Healthcare myAirvo 2 Sysytem

Deliver humidified high flows from 2-60 L/min to chronic respiratory patients at home or in long-term care facilities. Humidified high flow therapy has been shown to ease symptoms such as frequent coughs and breathlessness as well as reduce escalation of care in patients with conditions such as COPD. The myAirvo 2 is an innovative humidified high flow system that delivers the therapy through an Optiflow nasal cannula and a trio of advanced technologies.

• The myAirvo 2 algorithm’s intelligent controls deliver Optimal Humidity to patients at 37, 34 or 31 °C.
• A uniquely designed air pathway thoroughly conditions the mix of air and oxygen to accurately deliver the patient’s set flow rate.
• The two-spiral design produces up to 93% less condensate*, maximizing humidity levels of the breathing gas.